SectorBiological Technology
Established Date18/11/1994
Listing Date08/09/2020
ExchangeNASDAQ Stock Exchange
Full-time Employees88
Fiscal Year Ends31/12
Security TypeDepository Receipts (Ordinary Shares)
Office address12 Hammersmith Grove, London, United Kingdom W6 7AP
Business
IntroductionSilence Therapeutics Plc was incorporated on 18 November 1994 as a public limited company under the laws of England and Wales. The company is a biotechnology company focused on the discovery and development of new molecules, including short interfering ribonucleic acid (siRNA), to inhibit the expression of specific target genes that are thought to play a role in the pathological processes of diseases with significant unmet medical needs.
